ARKG Holdings of VRTX
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for treating serious diseases, with a strong emphasis on cystic fibrosis. The company generates revenue primarily through the sale of its approved medications and collaboration agreements with other firms in the biopharmaceutical industry.
Trades of VRTX in ARKG
The ten most recent trades of Vertex Pharmaceuticals in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Nov 15, 2024 | Sell | $3,011,577 | 20.25% | 0.24% |
| Nov 06, 2024 | Sell | $2,624,673 | 14.31% | 0.21% |
| Oct 25, 2024 | Sell | $241,254 | 1.35% | 0.02% |
| Oct 24, 2024 | Sell | $2,378,074 | 11.78% | 0.20% |
| Oct 08, 2024 | Sell | $257,807 | 1.31% | 0.02% |
| Oct 07, 2024 | Sell | $1,602,510 | 7.62% | 0.13% |
| Sep 23, 2024 | Sell | $265,736 | 1.22% | 0.02% |
| Sep 11, 2024 | Sell | $1,104,487 | 4.76% | 0.09% |
| Aug 08, 2024 | Sell | $2,553,781 | 9.91% | 0.20% |
| May 30, 2024 | Sell | $2,039,302 | 5.78% | 0.15% |